ctrl K

Watchlist Price Alert

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

10.11

-0.26 (-2.51%)

At close: Jun 16, 2025, 10:04 AM

MBX Biosciences Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023
Cash & Equivalents	29.9M	49.35M	132.87M	12.5M	35.42M	30.52M
Short-Term Investments	210.88M	212.8M	144.2M	42.76M	34.89M	50.15M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	50K	50K	50K	2.8M	1.74M	50K
Receivables	n/a	682K	858K	164K	199K	208K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.49M	803K	838K	242K	168K	133K
Total Current Assets	244.28M	267.29M	281.17M	58.8M	72.7M	83.47M
Property-Plant & Equipment	1.6M	1.2M	1.18M	1.28M	880K	665K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.65M	1.25M	1.23M	4.08M	2.62M	715K
Total Assets	245.93M	268.54M	282.4M	62.88M	75.32M	84.18M
Account Payables	4.25M	5.33M	5M	3.22M	3.2M	1.39M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	130K	n/a	n/a	n/a	157K	n/a
Other Current Liabilities	6.11M	2.32M	1.85M	1.12M	1.57M	1.36M
Total Current Liabilities	10.48M	11.05M	10.92M	8.2M	5.7M	3.93M
Long-Term Debt	n/a	n/a	n/a	n/a	185K	n/a
Other Long-Term Liabilities	23K	42K	68K	152.48M	n/a	152.55M
Total Long-Term Liabilities	23K	42K	112K	152.57M	314K	152.72M
Total Liabilities	10.5M	11.09M	11.03M	160.77M	6.01M	156.65M
Total Debt	130K	171K	210K	249K	471K	324K
Common Stock	5K	5K	5K	2K	1K	1K
Retained Earnings	-161.38M	-137.5M	-121.92M	-103.78M	-87.92M	-75.58M
Comprehensive Income	53K	55K	106K	-15K	-3K	60K
Shareholders Equity	235.42M	257.44M	271.37M	-97.89M	69.31M	-72.47M
Total Investments	n/a	212.8M	144.2M	42.76M	34.89M	50.15M